Literature DB >> 28248518

A Gradient of Sitewise Diversity Promotes Evolutionary Fitness for Binder Discovery in a Three-Helix Bundle Protein Scaffold.

Daniel R Woldring1, Patrick V Holec1, Lawrence A Stern1, Yang Du2, Benjamin J Hackel1.   

Abstract

Engineered proteins provide clinically and industrially impactful molecules and utility within fundamental research, yet inefficiencies in discovering lead variants with new desired functionality, while maintaining stability, hinder progress. Improved function, which can result from a few strategic mutations, is fundamentally separate from discovering novel function, which often requires large leaps in sequence space. While a highly diverse combinatorial library covering immense sequence space would empower protein discovery, the ability to sample only a minor subset of sequence space and the typical destabilization of random mutations preclude this strategy. A balance must be reached. At library scale, compounding several destabilizing mutations renders many variants unable to properly fold and devoid of function. Broadly searching sequence space while reducing the level of destabilization may enhance evolution. We exemplify this balance with affibody, a three-helix bundle protein scaffold. Using natural ligand data sets, stability and structural computations, and deep sequencing of thousands of binding variants, a protein library was designed on a sitewise basis with a gradient of mutational levels across 29% of the protein. In direct competition of biased and uniform libraries, both with 1 × 109 variants, for discovery of 6 × 104 ligands (5 × 103 clusters) toward seven targets, biased amino acid frequency increased ligand discovery 13 ± 3-fold. Evolutionarily favorable amino acids, both globally and site-specifically, are further elucidated. The sitewise amino acid bias aids evolutionary discovery by reducing the level of mutant destabilization as evidenced by a midpoint of denaturation (62 ± 4 °C) 15 °C higher than that of unbiased mutants (47 ± 11 °C; p < 0.001). Sitewise diversification, identified by high-throughput evolution and rational library design, improves discovery efficiency.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28248518      PMCID: PMC5521020          DOI: 10.1021/acs.biochem.6b01142

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  95 in total

1.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations.

Authors:  Raphael Guerois; Jens Erik Nielsen; Luis Serrano
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

2.  Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling.

Authors:  Benjamin J Hackel; Atul Kapila; K Dane Wittrup
Journal:  J Mol Biol       Date:  2008-06-24       Impact factor: 5.469

3.  Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code.

Authors:  Frederic A Fellouse; Pierre A Barthelemy; Robert F Kelley; Sachdev S Sidhu
Journal:  J Mol Biol       Date:  2005-12-19       Impact factor: 5.469

4.  Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold.

Authors:  Akiko Koide; John Wojcik; Ryan N Gilbreth; Robert J Hoey; Shohei Koide
Journal:  J Mol Biol       Date:  2011-12-16       Impact factor: 5.469

5.  Monitored whole gene in vitro evolution of an anti-hRaf-1 affibody molecule towards increased binding affinity.

Authors:  Sebastian Grimm; Samaneh Salahshour; Per-Åke Nygren
Journal:  N Biotechnol       Date:  2011-10-19       Impact factor: 5.079

6.  Structural basis for high-affinity HER2 receptor binding by an engineered protein.

Authors:  Charles Eigenbrot; Mark Ultsch; Anatoly Dubnovitsky; Lars Abrahmsén; Torleif Härd
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

7.  Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.

Authors:  P-A Löfdahl; O Nord; L Janzon; P-A Nygren
Journal:  N Biotechnol       Date:  2009-07-01       Impact factor: 5.079

8.  Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.

Authors:  Michael Zemlin; Martin Klinger; Jason Link; Cosima Zemlin; Karl Bauer; Jeffrey A Engler; Harry W Schroeder; Perry M Kirkham
Journal:  J Mol Biol       Date:  2003-12-05       Impact factor: 5.469

9.  High-affinity binders selected from designed ankyrin repeat protein libraries.

Authors:  H Kaspar Binz; Patrick Amstutz; Andreas Kohl; Michael T Stumpp; Christophe Briand; Patrik Forrer; Markus G Grütter; Andreas Plückthun
Journal:  Nat Biotechnol       Date:  2004-04-18       Impact factor: 54.908

10.  Selection and characterization of Affibody ligands to the transcription factor c-Jun.

Authors:  Emma Lundberg; Hjalmar Brismar; Torbjörn Gräslund
Journal:  Biotechnol Appl Biochem       Date:  2009-01       Impact factor: 2.431

View more
  13 in total

1.  Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276.

Authors:  Lawrence A Stern; Patrick S Lown; Alexandra C Kobe; Lotfi Abou-Elkacem; Juergen K Willmann; Benjamin J Hackel
Journal:  ACS Comb Sci       Date:  2019-01-24       Impact factor: 3.784

2.  Constrained Combinatorial Libraries of Gp2 Proteins Enhance Discovery of PD-L1 Binders.

Authors:  Max A Kruziki; Vidur Sarma; Benjamin J Hackel
Journal:  ACS Comb Sci       Date:  2018-06-05       Impact factor: 3.784

3.  High-throughput developability assays enable library-scale identification of producible protein scaffold variants.

Authors:  Alexander W Golinski; Katelynn M Mischler; Sidharth Laxminarayan; Nicole L Neurock; Matthew Fossing; Hannah Pichman; Stefano Martiniani; Benjamin J Hackel
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

4.  Validation and Stabilization of a Prophage Lysin of Clostridium perfringens by Using Yeast Surface Display and Coevolutionary Models.

Authors:  Seth C Ritter; Benjamin J Hackel
Journal:  Appl Environ Microbiol       Date:  2019-05-02       Impact factor: 4.792

5.  Computationally Aided Discovery of LysEFm5 Variants with Improved Catalytic Activity and Stability.

Authors:  Tsvetelina H Baryakova; Seth C Ritter; Daniel T Tresnak; Benjamin J Hackel
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

6.  Noncompetitive Allosteric Antagonism of Death Receptor 5 by a Synthetic Affibody Ligand.

Authors:  Nagamani Vunnam; Sophia Szymonski; Petra Hirsova; Gregory J Gores; Jonathan N Sachs; Benjamin J Hackel
Journal:  Biochemistry       Date:  2020-09-30       Impact factor: 3.162

7.  Affibody-Indocyanine Green Based Contrast Agent for Photoacoustic and Fluorescence Molecular Imaging of B7-H3 Expression in Breast Cancer.

Authors:  Rakesh Bam; Makenna Laffey; Katharine Nottberg; Patrick S Lown; Benjamin J Hackel; Katheryne E Wilson
Journal:  Bioconjug Chem       Date:  2019-05-24       Impact factor: 4.774

8.  Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast.

Authors:  Patrick S Lown; Benjamin J Hackel
Journal:  ACS Comb Sci       Date:  2020-04-27       Impact factor: 3.784

Review 9.  Recent advances in automated protein design and its future challenges.

Authors:  Dani Setiawan; Jeffrey Brender; Yang Zhang
Journal:  Expert Opin Drug Discov       Date:  2018-04-25       Impact factor: 6.098

10.  Extended yeast surface display linkers enhance the enrichment of ligands in direct mammalian cell selections.

Authors:  Patrick S Lown; Jessy J Cai; Seth C Ritter; Jacob J Otolski; Ryan Wong; Benjamin J Hackel
Journal:  Protein Eng Des Sel       Date:  2021-02-15       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.